Mochi Health: Specific Patient Profiles Who Should Avoid It (and Why) Mochi Health: Specific Patient Profiles Who Should Avoid It At a glance Service type / GLP-1 telehealth (insurance + cash-pay) Primary medications offered / Semaglutide, tirzepatide, compounded GLP-1 agents Monthly membership fee / Approximately $99/month (as of early 2025) Insurance accepted / Yes, select plans BBB accreditation / Not accredited as of January 2025 FDA-cleared drugs available / Yes (Wegovy, Ozempic, Mounjaro, Zepbound) Key contraindicated profiles / MTC/MEN2 history, active eating disorder, pregnancy, severe renal/hepatic disease LegitScript status / Not certified as of January 2025 Prescriber type / Physician and nurse practitioner-staffed asynchronous + synchronous visits Compounded GLP-1 risk / Compounded semaglutide from 503A/503B pharmacies carries FDA safety warnings What Is Mochi Health and How Does It Work
Professional Use Only This product is intended for use by qualified healthcare professionals in clinical, institutional, and professional settings only
[DOI] [PubMed] [Google Scholar] 6.Lebrun LJ, et al
Hypothalamic carnitine metabolism integrates nutrient and hormonal feedback to regulate energy homeostasis
GLP-1 can trigger nausea and constipation
